Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Cancer Cell cycle Kinases/phosphatases Cdks

Human Cell Cycle In-Cell ELISA kit (IR) (ab139412)

Human Cell Cycle In-Cell ELISA kit (IR) (ab139412)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Assay type: Cell-based (quantitative)
  • Detection method: Colorimetric
  • Sample type: Adherent cells, Suspension cells
  • Reacts with: Mouse, Human

You may also be interested in

Product image
Anti-Cdk1 + Cdk2 (phospho T14) antibody [EPR17499] (ab183550)
Product image
Anti-Cdk2 antibody (ab64669)
Product image
Recombinant Human CDK1 protein (denatured) (ab202615)
Product image
Anti-Cdk3 antibody (ab191503)

Overview

  • Product name

    Human Cell Cycle In-Cell ELISA kit (IR)
  • Detection method

    Colorimetric
  • Precision

    Intra-assay
    Sample n Mean SD CV%
    Histone H3 3.9%
    Cdk2 4.4%
  • Sample type

    Adherent cells, Suspension cells
  • Assay type

    Cell-based (quantitative)
  • Assay duration

    Multiple steps standard assay
  • Species reactivity

    Reacts with: Mouse, Human
  • Product overview

    Human Cell Cycle In-Cell ELISA kit (IR) (ab139412) that uses quantitative immunocytochemistry to measure levels of Cdk2 protein phosphorylated Tyr15 and Histone H3 protein phosphorylated Ser10 levels in cultured cells. Cells are fixed in a microplate and targets of interest are detected with highly specific, well-characterized antibodies. Relative target levels are quantified using IRDye®-labeled Secondary Antibodies and IR imaging such as a LI-COR® Odyssey® or Aerius® system. Antibody signal intensity can be normalized to the total cell amount using Janus Green stain.


    Plates are available in our ICE (In-Cell ELISA) Support Pack (ab111542) which can be bought seperately.

  • Notes

    The Cdk2 (pTyr15) + Histone H3 (pSer10) In-Cell ELISA Kit (IR) (ab139412) is designed to study cell cycle effects in response to various stimuli. Monoclonal antibodies specific to Cdk2 (pTyr15) and Histone H3 (pSer10) are used in this high-throughput duplexing plate-based assay. Cdk2 (pTyr15) is elevated in G1/S phase of the cell cycle and Histone H3 (pSer10) is elevated in G2/M phase. Cyclin-dependent kinase 2 (Cdk2) is a nuclear protein kinase that functions in the G1/S phase of the cell cycle. Inhibitory phosphorylation occurs on residues Thr14 and Tyr15; activation of Cdk2 includes dephosphorylation of these residues by cdc25. Cdk2 can form a complex with Cyclin A, D or E. Phosphorylation of Cdk2 at Tyr15 indicates that a cell is at the G1/S transition.

    Histone H3 is one of the four core histone proteins (H2A, H2B, H3 and H4) that pack DNA in nucleosomes. Post-translational modifications of histones include phosphorylation and acetylation and are important for chromatin assembly and gene expression. Phosphorylation of Histone H3 at Ser10 is tightly correlated with chromosome condensation during mitosis. Hence, Histone H3 pSer10 signal indicates a mitotic cell with condensed DNA.

    In-Cell ELISA (ICE) technology employed to perform quantitative immunocytochemistry of cultured cells with a near-infrared fluorescent dye-labeled detector antibody. The technique generates quantitative data with specificity similar to western blotting, but with much greater quantitative precision and higher throughput due to the greater dynamic range and linearity of direct fluorescence detection and the ability to run 96 samples in parallel. Because the Cdk2 (pTyr15) antibody is a rabbit antibody and the Histone H3 (pSer10) antibody is a mouse antibody, they can be measured simultaneously in the same well using the cocktail of provided primary antibodies and the provided cocktail of IRDye®-labeled species-specific secondary antibodies when using a LI-COR infrared imager. This method rapidly fixes the cells in situ, stabilizing the in vivo levels of proteins and their post-translational modifications, and thus eliminating changes during sample handling, such as in the preparation of protein extracts. Finally, the Cdk2 (pTyr15) and Histone H3 (pSer10) signals can be normalized to cell amount, measured by the provided Janus Green whole cell stain, to further increase the assay precision.

    Abcam has not and does not intend to apply for the REACH Authorisation of customers’ uses of products that contain European Authorisation list (Annex XIV) substances.
    It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

  • Platform

    Microplate

Properties

  • Storage instructions

    Store at +4°C. Please refer to protocols.
  • Components 1 x 96 tests
    1000X IRDye-labeled Secondary Antibodies 1 x 24µl
    100X Anti- Histone H3 (pSer10) Primary Antibody 1 x 120µl
    100X Anti-Cdk2 (pTyr15) Primary Antibody 1 x 120µl
    100X Triton X-100 1 x 500µl
    10X Blocking Solution 1 x 10ml
    10X Phosphate Buffered Saline 1 x 100ml
    400X Tween-20 1 x 2ml
    1X Janus Green Stain 1 x 17ml
  • Research areas

    • Cell Biology
    • Cell Cycle
    • Kinases/Phosphatases
    • Cdks
    • Epigenetics and Nuclear Signaling
    • Histones
    • H3
    • Unmodified
    • Epigenetics and Nuclear Signaling
    • Cell cycle
    • Kinases/Phosphatases
    • Cdks
    • Cancer
    • Cell cycle
    • Kinases/phosphatases
    • Cdks
  • Relevance

    CdK2 is a member of the Ser/Thr protein kinase family. This protein kinase is highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2. It is a catalytic subunit of the cyclin-dependent protein kinase complex, whose activity is restricted to the G1-S phase, and essential for cell cycle G1/S phase transition. This protein associates with and regulated by the regulatory subunits of the complex including cyclin A or E, CDK inhibitor p21Cip1 (CDKN1A) and p27Kip1 (CDKN1B). Its activity is also regulated by its protein phosphorylation. Two alternatively spliced variants and multiple transcription initiation sites of this gene have been reported.
  • Cellular localization

    Cytoplasmic and Nuclear
  • Alternative names

    • Cdc2 related protein kinase
    • Cell devision kinase 2
    • Cell division protein kinase 2
    • Cyclin dependent kinase 2
    • H3 histone family, member T
    • H3.4
    • H3/g
    • H3/t
    • H3FT
    • H3t
    • Histone 3, H3
    • Histone cluster 3, H3
    • Histone H3.1t
    • p33 protein kinase
    • p33(CDK2)
    see all
  • Database links

    • Entrez Gene: 1017 Human
    • Entrez Gene: 8290 Human
    • Entrez Gene: 12566 Mouse
    • Omim: 116953 Human
    • Omim: 602820 Human
    • SwissProt: P24941 Human
    • SwissProt: Q16695 Human
    • SwissProt: P97377 Mouse

    Images

    • Sample IR data using ab139412 on HeLa cells treated with Paclitaxel and Hydroxyurea.
      Sample IR data using ab139412 on HeLa cells treated with Paclitaxel and Hydroxyurea.
      HeLa cells were treated for 24h with varying concentrations of paclitaxel (0.26 – 2000 µM). Histone H3 pSer10 (red) intensity increases with increasing paclitaxel whereas Cdk2 pTyr15 (green) intensity decreases. This is the expected result for paclitaxel treatment: mitotic arrest. (B) HeLa cells were treated for 24h with varying concentrations of hydroxyurea (0.002 – 5 mM). Histone H3 pSer10 (red) intensity decreases with increasing paclitaxel whereas Cdk2 pTyr15 (green) intensity increases. This is the expected result for hydroxyurea treatment: G1/S-phase arrest.
    • Sample experiment using ab139412 on HeLa cells treated with paclitaxel and hydroxyurea.
      Sample experiment using ab139412 on HeLa cells treated with paclitaxel and hydroxyurea.
      Quantification of the data shown in Image 1. Data shown is for 24 hour treatment with 1 mM hydroxyurea, 333 nM paclitaxel and untreated (Control).
    • Sample data using ab139412 on HeLa cells treated with a titration of hydroxyurea.
      Sample data using ab139412 on HeLa cells treated with a titration of hydroxyurea.
      Cdk2 pTyr15 intensity increases with Hydroxyurea treatment dose whereas Histone H3 pSer10 intensity decreases.
    • Antibody specificity demonstrated by Western Blot Analysis.
      Antibody specificity demonstrated by Western Blot Analysis.
      Whole cell lysates from HeLa cells were analyzed by western blot with the primary antibodies used in this assay kit. (A) Histone H3 pSer10 antibody: untreated (lane 1), hydroxyurea = G1/S arrest (lane 2), paclitaxel = G2/M arrest (lane 3). (B) Cdk2 pTyr15 antibody: untreated (lane 1), thymidine = G1/S arrest (lane 2), nocodazole = G2/M arrest (lane 3).

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com

    Alternative products to Human Cell Cycle In-Cell ELISA kit (IR) (ab139412)

    •  
    • Product image

      Cell Cycle (pCdk/pHH3/Actin) WB Cocktail (ab136810)

      Applications:

    •  
    • Product image

      Cell Cycle In-Cell ELISA Kit (Fluorescent) (ab140363)

      Applications:

    Clear all

    Recently viewed products

    •  
    • Human ULK1 knockout A549 cell line (ab277825)

    Get resources and offers direct to your inbox Sign up
    © 2021 Astana Biomed Group LLP. All rights reserved.